The newly issued U.S. Patent No. 10,755,138 covers the application of point-wise mutual information maps to quantify spatial intratumor heterogeneity and identify diagnostic regions of interest in tissue samples. This patent has been exclusively licensed to PredxBio, Inc. from the University of Pittsburgh and further adds to the strong and growing IP portfolio of PredxBio around spatial analytics, xAI and spatial network biology.
PredxBio at AACR 2022
PredxBio is ushering a new era of unbiased spatial analytics and explainable AI in precision pathology at AACR 2022 PredxBio announces that it will attend